Clinical trials are the most important part of drug discovery and also for various treatment research.

A survey carried out by Memorial Sloan Kettering Cancer Center among 1,500 adults in the age group of 18-69 years found that just four in 10 Americans have a positive impression of clinical trials and only about one-third of Americans would be likely to enroll in one.
The causes of concern were side effects and efficacy of the experimental drug, insurance coverage, out-of-pocket costs, inconvenient trial locations and the fear of receiving a placebo instead of an active treatment drug.
“The findings are cause for concern in terms of cancer research because nearly every advance in cancer was first evaluated in a clinical trial. If this trend of low enrollment continues, we will face a crisis in cancer research and discovery. Further education is the key to participation and progress," said Dr. Jose Baselga, physician-in-chief and chief medical officer at the cancer center.
Source-Medindia
MEDINDIA













